Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.

Source:http://linkedlifedata.com/resource/pubmed/id/10508276

Download in:

View as

General Info

PMID
10508276